Uzin Utz (UZU) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
21 Jul, 2026Executive summary
Achieved record revenue of €505.1 million in 2025, up 6.1% year-over-year, surpassing €500 million for the first time.
EBIT declined 5.6% to €40.4 million, with an EBIT margin of 8.0%, aligning with strategic targets.
Growth was driven by higher sales volumes across all core, growth, and aspirant markets, especially in the Netherlands, USA, and Poland.
Strategic acquisitions and investments in sustainability and automation, including BIOFA Naturprodukte and an 8.8% stake in ConBotics GmbH.
New GROW BIGGER strategy launched for 2026–2030, focusing on international expansion, innovation, and sustainable growth.
Financial highlights
Revenue: €505.1 million (+6.1% YoY); EBIT: €40.4 million (-5.6% YoY); Net income: €26.5 million (-10.2% YoY).
Gross profit margin stable at 58.5%; cost of materials ratio at 41.5%.
Personnel expenses rose to €141.5 million (27.7% of revenue) due to headcount and wage increases.
Cash flow from operating activities dropped to €33.9 million (from €53.1 million), mainly due to higher inventories and receivables.
Dividend proposed at €1.90 per share.
Outlook and guidance
Forecasts slight revenue growth for 2026, supported by the GROW BIGGER strategy and expansion into new markets.
EBIT expected to remain stable; EBIT margin may decline slightly due to increased investments and personnel costs.
Operating cash flow anticipated to increase as inventory growth normalizes.
Planned investments of €28.6 million in 2026, mainly in Germany, R&D, and IT modernization.
Latest events from Uzin Utz
- EBIT and EBITDA grew despite lower sales, with a positive share price and stable outlook.UZU
Q3 202421 Jul 2026 - EBIT rose 13.7% to €19.9 million despite a 1.0% revenue decline, with margin improvement.UZU
Q2 202421 Jul 2026 - Q1 2025 saw sales and EBIT growth, but global trade and policy risks remain elevated.UZU
Q1 202521 Jul 2026 - Sales and profits rose in H1 2025, but EBIT margin is expected to decline slightly for the year.UZU
Q2 202521 Jul 2026 - Q3 2025 saw double-digit sales and EBIT growth, but outlook remains cautious amid global risks.UZU
Q3 202521 Jul 2026 - EBIT surged 24.1% to €42.8m on stable sales and improved cost efficiency.UZU
Q4 202421 Jul 2026 - Q1 2026 revenue rose 6.6% but EBIT dropped 14.2% amid higher costs and global tensions.UZU
Q1 202621 Jul 2026